GlassScriptPhysician profile
Arif Muslim
NPI 1053534578
$15,499.02
in general payments reported to CMS, 2019-2025
60 companies · $3,320 in 2025
The $3,320 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,479 · 2020: $1,584 · 2021: $1,499 · 2022: $1,726 · 2023: $2,408 · 2024: $2,483 · 2025: $3,320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,152 · Education: $59.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,151.97 |
| Education | $59.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,135.63 | 2019-2025 | |
| Gilead Sciences, INC. | $1,596.35 | 2019-2025 | Livdelzi, Epclusa |
| Janssen Biotech, INC. | $1,084.36 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Boston Scientific Corporation | $869.82 | 2021-2025 | Overstitch Endoscopic Suturing System, Spyglass, Hurricane Rx |
| Genzyme Corporation | $807.17 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $667.01 | 2019-2023 | Trulance |
| Madrigal Pharmaceuticals | $633.55 | 2024-2025 | Rezdiffra, Resmetirom |
| Intercept Pharmaceuticals, INC. | $624.25 | 2019-2025 | Ocaliva |
| Pfizer INC. | $611.42 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $541.71 | 2019-2025 | Entyvio, Eohilia, Gattex |
| Janssen Scientific Affairs, LLC | $477.25 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $445.33 | 2021-2024 | Zeposia |
| Celgene Corporation | $365.35 | 2022-2024 | Zeposia |
| Phathom Pharmaceuticals, INC. | $356.79 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $329.53 | 2023-2025 | Omvoh, Taltz, Zepbound |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $244.05 | 2020-2023 | Axonics |
| Aimmune Therapeutics, INC. | $243.94 | 2024-2025 | Zenpep |
| Regeneron Healthcare Solutions, INC. | $176.22 | 2023-2024 | Dupixent |
| Ardelyx, INC. | $168.70 | 2022-2025 | Ibsrela |
| Capsovision, INC. | $158.25 | 2024 | Capsocam Plus |
| Sumitomo Pharma America, INC. | $146.00 | 2024-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $134.54 | 2020-2024 | Xyosted |
| Endo Pharmaceuticals INC. | $127.41 | 2019-2023 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $113.22 | 2020-2022 | |
| Urogen Pharma, INC. | $85.62 | 2022-2025 | Jelmyto |
| Qol Medical, LLC | $84.05 | 2019-2023 | Sucraid |
| Braintree Laboratories, INC. | $83.86 | 2019-2023 | Sutab, Suflave |
| Ipsen Biopharmaceuticals, INC | $80.85 | 2025 | Iqirvo |
| Merck Sharp & Dohme LLC | $79.91 | 2019-2025 | Keytruda |
| Redhill Biopharma INC. | $77.18 | 2020-2021 | |
| Allergan, INC. | $72.56 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $71.30 | 2020-2022 | |
| 180 Medical, INC. | $65.28 | 2020-2025 | |
| Teleflex LLC | $53.67 | 2022-2025 | Barrigel |
| Urovant Sciences INC | $52.06 | 2022 | |
| Endo USA, INC. | $47.20 | 2024 | Xiaflex |
| Ani Pharmaceuticals, INC. | $39.15 | 2023-2025 | Purified Cortrophin Gel |
| Therapeuticsmd, INC. | $36.35 | 2020-2021 | |
| Amgen INC. | $34.76 | 2022-2023 | Enbrel, Otezla |
| Myriad Genetic Laboratories, INC. | $33.36 | 2023-2024 | Prolaris, Myrisk |
| Novo Nordisk INC | $31.66 | 2025 | Wegovy |
| Coloplast Corp | $29.26 | 2021-2022 | |
| Radius Health, INC. | $29.13 | 2025 | Tymlos |
| Medtronic, INC. | $28.73 | 2021-2024 | Interstim |
| Acerus Pharmaceuticals Corporation | $27.93 | 2021 | |
| Alfasigma USA, INC. | $27.30 | 2020 | |
| Evoke Pharma, INC. | $26.77 | 2023 | Gimoti |
| Verity Pharmaceuticals INC. | $25.14 | 2025 | Trelstar |
| Celltrion USA INC. | $22.29 | 2024 | Vegzelma |
| Bayer Healthcare Pharmaceuticals INC. | $21.76 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $21.74 | 2021 | |
| Procept Biorobotics Corporation | $21.53 | 2024 | Aquabeam System |
| Kerecis Limited | $21.46 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ucb, INC. | $18.98 | 2025 | Bimzelx |
| Progenics Pharmaceuticals, INC. | $18.82 | 2024 | |
| Ironwood Pharmaceuticals, INC | $18.26 | 2020 | |
| Abc Home Medical Supply, INC. | $17.88 | 2025 | |
| Concordia Pharmaceuticals INC. | $16.19 | 2019 | |
| Genentech USA, INC. | $15.36 | 2025 | Actemra |
| Romark Laboratories, Lc | $3.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arif Muslim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.